They discovered RASAL1 gene-disabling mutations and promoter hypermethylation in thyroid cancer samples, predominantly FTC and ATC, suggesting the RASAL1 is a key TSG in thyroid cancer. The gene discussed is RASAL1; the disease is thyroid gland carcinoma.